Stoke Therapeutics Inc buy Credit Suisse Group AG
Start price
08.08.23
/
50%
€4.88
Target price
08.08.24
€21.00
Performance (%)
162.30%
End price
09.08.24
€12.80
Summary
This prediction ended on 09.08.24 with a price of €12.80. With a performance of 162.30% the BUY prediction by Credit_Suisse_Group_ was a big success. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | -3.472% | -3.472% | 379.310% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $23.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Credit_Suisse_Group_ gewählte maximale Laufzeit wurde überschritten